• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

5 Top Women's Health Apps

Slideshow

What women want these 5 apps offer: access to user-friendly technology that supports a wide range of health issues exclusive to them. Get the highlights.

Mobile applications that cater to the highly specific health interests of women are entering the market at a rapid pace. They offer everything from the opporutnity to track peculiarities of an individual's menstrual cycle to direct access to prescriptions for oral contraceptives. Our app reviewer has selected 5 for this review based on their potential for recommendation by primary care physicians. Above we offer highlights of:Glow Ovulation, Period Tracker nurx - Birth Control Pills Breast Cancer: Beyond the Shock Maven Clinic Clue Period & Health Tracker

Related Content
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

Patient Care Editorial Staff
October 25th 2024
Article

Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.

FDA Updates Flublok Label with Safety Data for Pregnant Individuals / image credit pregnancy vaccination concept / ©Dmitry Naumov/stock.adobe.com

FDA Updates Flublok Label with Safety Data for Pregnant Individuals

Grace Halsey
October 23rd 2024
Article

The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.

Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause / image courtesy of Bayer

Elinzanetant Data from Bayer Feature Prominently at 19th World Congress on Menopause

Grace Halsey
October 17th 2024
Article

Bayer announced 12 presentations focused on symptoms of menopause and effects of its investigational oral nonhormonal medication elinzanetant.

Why Are Women Still Missing from Cardiovascular Clinical Trials? image credit ©Chinnapong/stock.adobe.com

Why Are Women Still Missing from Cardiovascular Clinical Trials?

Hayden E. Klein
October 17th 2024
Article

Women remain underrepresented in heart disease research after decades of efforts to correct the balance, affecting trial data and women's cardiovascular care.

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic / Image credit: ©sopradit/AdobeStock

FDA Grants Priority Review to GSK NDA for First-In-Class Oral Antibiotic

Sydney Jennings
October 16th 2024
Article

The FDA today accepted GSK's NDA for gepotidacin for the treatment of uncomplicated urinary tract infections in women and adolescents.

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date / image credit FDA logo ©Araki Illustrations/stock.adobe.com

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date

Grace Halsey
October 11th 2024
Article

The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.

© 2024 MJH Life Sciences

All rights reserved.